SunLink Health Systems, Inc.
SSY · AMEX
6/30/2024 | 6/30/2023 | 6/30/2022 | 6/30/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.14 | -0.89 | 0.03 | -0.00 |
| FCF Yield | -78.95% | -39.77% | -45.99% | -5.21% |
| EV / EBITDA | 2.23 | -1.80 | -0.37 | 5.57 |
| Quality | ||||
| ROIC | -14.38% | -12.29% | -27.58% | 7.34% |
| Gross Margin | 39.78% | 49.84% | 48.63% | 53.12% |
| Cash Conversion Ratio | 1.95 | 0.30 | 0.00 | 0.20 |
| Growth | ||||
| Revenue 3-Year CAGR | -7.77% | 5.63% | -4.73% | -3.74% |
| Free Cash Flow Growth | -75.00% | 20.48% | -159.67% | -144.18% |
| Safety | ||||
| Net Debt / EBITDA | 14.66 | 2.06 | 1.46 | -1.74 |
| Interest Coverage | 0.00 | 0.00 | -356.00 | 66.82 |
| Efficiency | ||||
| Inventory Turnover | 12.58 | 13.71 | 12.15 | 10.09 |
| Cash Conversion Cycle | 31.35 | 45.50 | 63.26 | 84.95 |